一种新型的宏分子结构是前兆细胞-氨酸受体蛋白的标
J A Dyck1, G G Maul, W H Miller
1Biomedical Sciences Graduate Progam University of California, San Diego, La Jolla 92037.
Cell
|January 28, 1994
概括
急性促细胞白血病涉及一个PML-RARα融合基因,破坏PML瘤原性域 (POD). 网氨酸治疗可以恢复PODs,这表明它们的破坏会导致白血病.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 急性前列细胞白血病 (APL) 的特征是t(15;17) 转位.
- 这种转位导致PML-RARα融合基因的形成.
- 该PML蛋白质是新型核结构的组成部分,称为PML瘤源域 (POD).
研究的目的:
- 调查PML瘤原性领域 (POD) 在APL.PATHOGENESIS中的作用.
- 了解PML-RARα瘤蛋白如何影响POD结构和功能.
- 探索POD作为APL治疗目标的潜力.
主要方法:
- 免疫组织化学被用来可视化PML和POD在APL细胞中.
- 研究了视网膜酸 (RA) 治疗对APL细胞中PODs的影响.
- 研究了PML-RARα对POD组件的影响机制.
主要成果:
- 瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤瘤
- 在APL细胞中,PML-RARα基蛋白破坏了正常的POD结构,导致了微粒子模式.
- 网氨酸治疗诱导了PML的重组,恢复了APL细胞中看起来正常的POD.
结论:
- 在PML-RAR阿尔法瘤蛋白以主导-负的方式作用,抑制POD组装.
- 建议通过PML-RARalpha破坏PODs,以损害骨髓细胞成熟,从而导致白血病发生.
- 瘤性PML域代表了急性前兆细胞白血病的潜在新型治疗标.
相关概念视频
Receptor-mediated Endocytosis
Overview
Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor-mediated Endocytosis
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Structure of Porins
Mitochondria, chloroplasts, and gram-negative bacteria have transmembrane, beta-barrel proteins called porins to mediate the free diffusion of ions and metabolites across the membrane. Mitochondrial porin precursors contain conserved amino acid sequences called beta signals at their C-terminal. Beta signals have a motif of PoXGXXHyXHy (Po-Polar, X-Any amino acid, G-Glycine, Hy-LargeHydrophobic), which are crucial for precursor recognition to initiate precursor assembly. Beta-barrel precursors...
Receptor-Mediated Endocytosis
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...


